Statistics
Total Visits
| Views | |
|---|---|
| Phase 1 trial of first-in-class ATR inhibitor VX-970 in combination with cisplatin (Cis) in patients (pts) with advanced solid tumors (NCT02157792) | 180 |
Total Visits Per Month
| March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | |
|---|---|---|---|---|---|---|---|
| Phase 1 trial of first-in-class ATR inhibitor VX-970 in combination with cisplatin (Cis) in patients (pts) with advanced solid tumors (NCT02157792) | 1 | 0 | 5 | 14 | 5 | 8 | 0 |
Top country views
| Views | |
|---|---|
| United States | 65 |
| Poland | 64 |
| Cyprus | 10 |
| China | 8 |
| India | 5 |
| Ireland | 4 |
| Australia | 1 |
| France | 1 |
| Greece | 1 |
| Macedonia | 1 |
Top cities views
| Views | |
|---|---|
| Warsaw | 64 |
| Menlo Park | 12 |
| Louisville | 11 |
| Limassol | 10 |
| San Ramon | 6 |
| Villa Park | 6 |
| Boardman | 5 |
| Beijing | 4 |
| Philadelphia | 4 |
| Ashburn | 3 |